A comparison of the effects of olanzapine, haloperidol and placebo on cognitive and psychomotor functions in healthy elderly volunteers

Journal of Psychopharmacology

Volumn 13, Issue 2, 1999, Pages 152-158

  Beuzen, J N ^a   Taylor, N ^a   Wesnes, K ^b   Wood, A ^a  

^a ELI LILLY AND COMPANY   (United States)

^b Cognitive Drug Research Ltd ^*  (United Kingdom)

Author keywords

Cognitive function; Computerized cognitive assessment; Elderly volunteers; Haloperidol; Olanzapine; Psychomotor effect

Indexed keywords

HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE;

ADAPTATION; ADULT; AGED; ARTICLE; ATTENTION; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIARRHEA; DOUBLE BLIND PROCEDURE; DROWSINESS; FATIGUE; FEMALE; FLATULENCE; HUMAN; HUMAN EXPERIMENT; MALE; MEMORY; MOTOR CONTROL; NORMAL HUMAN; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; RANDOMIZED CONTROLLED TRIAL; XEROSTOMIA;

EID: 0032998303     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988119901300207     Document Type: Article

References (16)

1. Bailie R, Christmas L, Restall J, Simpson P M, Wesnes K (1989) Effects of temazepam pre-medication on cognitive recovery following alfentanil/propofol anaesthesia. Br J Anaesthesiol 63: 68-75
2. Barker A, Jones R, Simpson P, Wesnes K (1995) Scopolamine-induced cognitive impairment as a predictor of cognitive decline in healthy elderly volunteers. Int J Geriatr Psychiatry 10: 1059-1062
3. Bond A, Lader M (1974) The use of analogue scales in rating subjective feelings. Br J Med Psychol 80: 1-46
4. Coulemans D, Gelders Y, Hoppenbrouwers M, Reyntijene A (1984) Proceedings of 14th CINP Congress, Florence, Italy
5. Fujii D E, Ahmed I, Jokumsen M, Compton J M (1997) The effects of clozapine on cognitive functioning in treatment-resistant schizophrenic patients. J Neuropsychiatry Clin Neurosci 9: 240-245
6. Goldberg T E, Weinberger D R (1996) Effects of neuroleptic medications on the cognition of patients with schizophrenia: a review of recent studies. J Clin Psychiatry 57 (Suppl.): 62-65
7. Goldberg T E, Greenberg R D, Griffin S J et al. (1993) The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia. Br J Psychiatry 162: 43-48
8. Kleinbloessem C H, Jaquet-Müller F, Hesse W H, Al-Hamdan Y, Forgo I, Brunner F, Wesnes K (1994) CNS and cardiovascular effects of RWJ-37796, a new antipsychotic, in healthy male subjects. J Clin Pharmacol 34: 1027
9. Miller R J, Hiley C R (1974) Antimuscarinic properties of neuroleptics and drug-induced parkinsonism. Nature 248: 596
10. van Harten J, Stevens L, Raghoebar M, Holland R, Wesnes K, Cournot A (1992) Fluvoxamine does not interact with alcohol or potentiate alcohol-related impairment of cognitive function. Clin Pharmacol Ther 52: 427-435
11. Wesnes K, Simpson P M, Christmas L (1987) The assessment of human information processing abilities in psychopharmacology. In Hindmarch I and Stonier PD (eds), Human psychopharmacology: measures and methods, vol. 1. John Wiley, Chichester, pp. 79-92
12. Wesnes K, Simpson P M, Kidd A G (1988) An investigation of the range of cognitive impairments induced by scopolamine 0.6 mg. Hum Psychopharmacol 3: 27-43
13. Wesnes K, Simpson P M, Christmas L, Anand R, McClelland G R (1989) The cognitive effects of moclobemide and trazodone alone and in combination with ethanol in healthy volunteers. Br J Clin Pharmacol 27: 647P-648P
14. Wesnes K, Jones R, Kirby J, Curtis L (1991) D-Cycloserine antagonises scopolamine induced memory impairment and improves attention in the elderly. Biol Psychiatry 29: 700-701S
15. Wesnes K, Simpson P M, Grimwood V, Rapeport G, Williams S (1994) An increased profile of cognitive impairment with acute doses of haloperidol 23 days apart. Annual Meeting of the British Association for Psychopharmacology, Cambridge, July
16. Wesnes K, de Koning P, Dietrich B (1995) A comparison of the cognitive effects of DU29894, sulpiride, haloperidol and a selective 5HT1A agonist in normal volunteers. Eur J Clin Invest 25 (Suppl. 2): A64